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Adolescence is of particular significance to schizophrenia, since psychosis onset typically
occurs in this critical period. Based on the N-methyl-D-aspartate (NMDA) receptor
hypofunction hypothesis of schizophrenia, in this study, we investigated whether and
how repeated NMDA receptor blockade during adolescence would affect GABAergic
interneurons in rat medial prefrontal cortex (mPFC) and mPFC-mediated cognitive
functions. Specifically, adolescent rats were subjected to intraperitoneal administration
of MK-801 (0.1, 0.2, 0.4 mg/kg), a non-competitive NMDA receptor antagonist, for
14 days and then tested for reference memory and reversal learning in the water maze.
The density of parvabumin (PV)-, calbindin (CB)- and calretinin (CR)-positive neurons
in mPFC was analyzed at either 24 h or 7 days after drug cessation. We found that
MK-801 treatment delayed reversal learning in the water maze without affecting initial
acquisition. Strikingly, MK-801 treatment also significantly reduced the density of PV+
and CB+ neurons, and this effect persisted for 7 days after drug cessation at the dose of
0.2 mg/kg. We further demonstrated that the reduction in PV+ and CB+ neuron densities
was ascribed to a downregulation of the expression levels of PV and CB, but not to
neuronal death. These results parallel the behavioral and neuropathological changes of
schizophrenia and provide evidence that adolescent NMDA receptors antagonism offers
a useful tool for unraveling the etiology of the disease.
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INTRODUCTION
It is now widely accepted that schizophrenia is a neurodevelopmental disorder (Fatemi and Folsom,
2009). In the past decades, vast research efforts have been made to identify the genetic and early
developmental factors that could contribute to the pathophysiology of the disease. Given that
psychosis onset typically occurs during adolescence, this critical developmental period is of obvious
significance for schizophrenia. However, until recently, few studies have attempted to investigate
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what maturational processes during adolescence are involved in
the etiology of schizophrenia (Rujescu et al., 2006; Braun et al.,
2007; Thomsen et al., 2010; Li et al., 2011; Le Magueresse and
Monyer, 2013; Thomases et al., 2013) and our understanding of
this issue is still limited.
Deficits in the inhibitory gamma-aminobutyric-acid (GABA)-
ergic interneurons have been consistently found in the
prefrontal cortex (PFC) of schizophrenic patients (Reynolds
et al., 2004). These deficits are thought to contribute to
the disturbances of PFC-dependent cognitive functions in
schizophrenia, since GABAergic transmission is critical for
normal cognitive functions via producing synchronized network
oscillations (Uhlhaas et al., 2006; Gonzalez-Burgos et al.,
2011). Notably, the functional maturation of the GABAergic
interneurons lasts until late adolescence and it has been
hypothesized that schizophrenia may be associated with the
disrupted development of these interneurons (Di Cristo, 2007;
Hoftman and Lewis, 2011; Caballero et al., 2014; Gonzalez-
Burgos et al., 2015). Of particular interest, the maturation
of GABAergic interneurons involves the N-methyl-D-aspartate
(NMDA) receptors (Thomases et al., 2013), which are highly
relevant to the pathophysiology of schizophrenia, considering
that blocking the NMDA receptors using its antagonists, such
as phencyclidine (PCP), MK-801 or ketamine, constitutes one
of the most widely used animal models for schizophrenia
(Jentsch and Roth, 1999). Accordingly, investigating how
repeated blockade of NMDA receptors during adolescence
would affect GABAergic interneurons in the PFC would
provide insight to the mechanisms underlying the onset of the
disease.
Three nonoverlapping classes of cortical GABAergic
interneurons can be identified according to the calcium-
binding proteins (CBPs) they contain: parvalbumin (PV),
calbindin (CB) and calretinin (CR), which together account for
more than 80% of total interneurons in rat medial prefrontal
cortex (mPFC; Gabbott et al., 1997). To our knowledge, few
studies have examined the effects of repeated NMDA receptor
antagonism during adolescence on various types of interneurons
in the mPFC (Braun et al., 2007; Thomsen et al., 2010). Among
these studies, conflicting results were reported: whereas Braun
et al. (2007) reported no significant change of PV-positive (PV+)
and CR+ cell counts in animals receiving MK-801, Thomsen
et al. (2010) noted reduced PV mRNA expression by PCP
treatment. Moreover, these effects were examined shortly after
drug cessation and it remains unknown about the long-term
influence of such treatment.
In this study, we aimed to investigate whether and how
subchronic NMDA receptor blockade during adolescence would
affect PFC-dependent cognitive functions and the density of
three subtypes of GABAergic interneurons in this region.
Previously, we have reported that subchronic MK-801 treatment
regimen induced deficits in the spatial working memory that is
mediated by mPFC (Li et al., 2011). Here, reversal learning in
the Morris water maze was conducted to further validate the
impairment of mPFC-dependent functions. We then assessed
the effects of MK-801 treatment on the three CBP-defined
subtypes of interneurons by cell counting at 24 h or 7 days
after drug cessation. Because the reduced cell densities could
reflect either a downregulation of CBP expression levels or a
loss of neurons, we further measured the number of apoptotic
cells and the expression levels of apoptosis-related molecules
(Bcl-2 and Bax) and three CBPs in the mPFC to reveal
which mechanism is responsible for the deficits in GABAergic
interneurons induced by repeated NMDA receptor blockade
during adolescence.
MATERIALS AND METHODS
Animals and Drug Treatment
Adolescent male Sprague-Dawley (SD) rats (n = 92, age 28 days,
weighing 90 ± 5 g) were used in the present study. Purchased
from the Laboratory of Animal Science (Peking University
Health Science Center, Beijing, China) after weaning at postnatal
day (PND) 21, animals were housed four per cage in a controlled
environment (23± 1◦C; 45–55% relative humidity; fixed 12/12 h
light/dark cycle, lights on at 08:00 h) with food and water
ad libitum. All procedures were performed in accordance with
the National Institute of Health’s Guide for the Use and Care of
Laboratory Animals and were approved by the Peking University
Committee on Animal Care and Use.
MK-801 (dizocilpine, St. Louis, MO, USA) was dissolved
in saline and stored at 4◦C. After 7-day habituation in the
animal facility, animals started to receive drug administration
on PND 29. They were randomly assigned into four groups
(n = 23 per group) and were given daily intraperitoneal
injection (2 ml/kg body weight) of MK-801 at doses of 0.1,
0.2, 0.4 mg/kg, or 0.9% saline (vehicle) between 09:00 and
10:20 h for 14 days. Body weights of animals were recorded
daily during drug treatment. Four animals from each group were
sacrificed at 24 h or 7 days after the last MK-801 treatment
for immunohistochemistry. Another five animals per group
were sacrificed 24 h after last MK-801 treatment for Western
blot. The other animals were tested in the Morris water maze
for reference memory 24 h after drug cessation and reversal
learning 7 days after drug cessation. A summary of animal
cohorts and the timing of various procedures are shown in
Figure 1.
Morris Water Maze Testing
The Morris water maze was used to assess reference memory
and reversal learning according to protocols previously reported
(Vorhees and Williams, 2006). A circular pool (185 cm in
diameter, 45 cm in height, made from dark plastic) was filled
with tap water (thermostatically controlled at 22 ± 1◦C).
A circular platform (9 cm in diameter) was submerged 1 cm
below the water surface for rats to climb onto once its
presence was detected. The pool was surrounded by a white
curtain, to which several pieces of colored paper in different
geometric shapes were attached to help rats obtain spatial
orientation. A camera suspended above the pool center was
used for recording the swimming path of the rats and video
outputs were analyzed using a video tracking and analysis
system.
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FIGURE 1 | Experimental timelines of behavioral and neurochemical procedures in three animal cohorts. PND, postnatal day; IHC, immunohistochemistry;
TUNEL, terminal deoxynucleotidyl transferase-mediated UTP nick end labeling; WB, western blot.
The reference memory task consisted of five consecutive days
of training to acquire the location of the hidden platform,
followed by a probe test on the sixth day without the platform.
The pool was divided into four equal imaginary Quadrants (I,
II, III and VI) and the platform was located at the center of
Quadrant III. On each training day, rats received four swimming
trials with each starting from different locations. Animals finding
the platformwithin 60 s were allowed to sit on it for 15 s and those
failing to do so were guided by the experimenter to the platform
and allowed to sit on it for 15 s. The inter-trial interval was 20 s.
After training, animals were dried with a towel and put in a clean
cage to avoid interaction with other animals. In the probe test,
rats were placed in the pool without the platform to swim for
60 s and their swimming time in each quadrant was collected and
analyzed.
The reversal learning task was performed after the reference
memory task. The platform was moved to the center of the
opposite quadrant (from Quadrant III to Quadrant I). Animals
were trained for four consecutive days followed by a probe trial
on the fifth day. The procedure was performed as described above
for the reference memory task.
Water maze performance in the acquisition phase was
expressed as the mean escape latency to the platform of four trials
in a training day. For the probe tests, the percentage time animals
swam in the target, adjacent and opposite quadrants were used as
an indication of spatial memory. The data of one animal in the
group of MK-801 0.1 mg/kg and one in the group of MK-801
0.4 mg/kg were excluded from analysis, because they frequently
jumped off the platform.
Immunohistochemistry
Immunohistochemistry was performed to quantify the number
and density of all GABAergic cells (identified as the cells
showing positive staining of the GABA synthesizing enzyme,
glutamic acid decarboxylase (GAD), which in adult brain has
two major isoforms, GAD65 and GAD67) and three major
subtypes of GABAergic interneurons (PV+, CB+ and CR+ cells).
At each sacrifice time point, animals (n = 4 per group) under
pentobarbital anesthesia were transcardially perfusedwith 250ml
cold saline solution, followed by 250 ml of 4% paraformaldehyde
in 0.1 M phosphate-buffered saline (PBS, pH 7.4). Brains were
removed, post-fixed in the same fixative overnight and stored
in 10, 20 and 30% sucrose solution at 4◦C for dehydration.
The brains were then quenched in cold N-hexane at −60◦C for
20 s and stored at−80◦C until required.
Serial coronal sections of the PFC (30 µm thick, bregma
3.72–2.52; Paxinos and Watson, 2005) were collected on a
cryostat (Leica, Wetzlar, Germany). Free-floating sections were
washed three times for 5 min in 0.1 M PBS and incubated
in 3% hydrogen peroxide for 10 min, followed by washing
steps and 90 min incubation in 1% normal goat serum. They
were labeled with the following primary antibodies overnight at
4◦C: GAD65/67 (rabbit anti-GAD65/67, 1:500; ab11070, Abcam,
Cambridge, UK), PV (rabbit anti-Parvalbumin, 1:20,000, PV 25,
Swant, Switzerland), CB (rabbit anti-calbindin, 1:20,000, CB-38a,
Swant), and CR (rabbit anti-calretinin, 1:5000, 7699/3H, Swant).
The next day, all slices were rinsed, incubated with secondary
antibodies (goat anti-rabbit IgG(H+L)/Biotin and goat anti-
mice IgG(H+L)/Biotin, Zhongshan Gold Bridge Biotechnology,
China) for 90 min at room temperature. After rinsing, the 3,3′-
Diaminobenzidine Horseradish Peroxidase Color Development
Kit was used for 5 min slice staining. Finally the sections were
transferred onto slides and coverslipped.
Images were obtained at 100× using an Olympus BX51
microscope equipped with a charge-coupled device (CCD)
camera (CoolSNAP MP5, Roper Scientific Corporation, USA)
and analyzed by the NIH ImageJ Software (National Institutes of
Health, Bethesda, MD, USA). We focused on three subregions
of mPFC (Figure 2): the cingulate cortex (Cg), the prelimbic
cortex (PrL) and infralimbic cortex (IL; Paxinos and Watson,
2005). To count the number of inhibitory interneurons within
each subregion, we defined regions of interest (ROI) as three
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FIGURE 2 | Schematic of three subregions of rat medial prefrontal cortex (mPFC), including the cingulate cortex (Cg), the prelimbic cortex (PrL)
and infralimbic cortex (IL), for immunohistochemistry analyses (A) and representative sections in the vehicle group immunostained for PV+ (B) CB+
(C) and CR+ (D) neurons.
nonoverlapping identical rectangles distributed evenly within
each subregion covering from the pial surface to the white matter
border (rectangle size: Cg 800 µm × 100 µm, PrL 600 µm ×
100 µm, IL 500 µm× 100 µm). The positive stained PV+, CB+,
CR+ and GAD65/67+ cells were counted within each ROI, which
were then averaged and divided by the area of the rectangle to
obtain the relative cell densities.
Double-Fluorescence
Immunohistochemistry
Since a subpopulation of pyramidal neurons in both superficial
and deep layers of mPFC was weakly stained for CB, as shown
in our own results and reported in previous studies (Gabbott
et al., 1997; Gonchar and Burkhalter, 1997; Caballero et al.,
2014), it is difficult to differentiate bonafide interneurons
from pyramidal neurons. To label specific CB+ interneuron
populations, we performed double-labeling immunofluorescence
to identify neurons that co-express CB and somatostatin (SST),
another selective interneuron marker. This procedure was
carried out on free-floating sections as described previously
(Chen et al., 2004). Briefly, after incubation with primary
antibodies (CB, rabbit anti-calbindin, 1:5000, CB-38a, Swant;
SST, goat anti-somatostatin, 1:100, sc-7819, Santa Cruz
Biotechnology) overnight at 4◦C, sections were rinsed and
labeled with anti-rabbit Alexa Fluor 488- and anti-goat
Alxea Fluor 594-conjugated donkey secondary antibodies
(1:500, Invitrogen, Karlsruhe, Germany) for 2 h at room
temperature. After rinsing, sections were transferred onto slides,
dried and coverslipped with Vectashield mounting medium
containing 4′,6-diamidino-2-phenylindole (Vector laboratories,
Burlingame, CA, USA).
The fluorescent images (1024 × 1024 pixels) were obtained
with an Olympus IX81 confocal microscope (Olympus, Tokyo,
Japan) at 10× magnification using the Kalman filter and
sequential scanning mode under identical settings for laser
power, photomultiplier gain and offset. For the colocalization
assessment of CB and SST, images were adjusted for better
brightness and contrast using the FV10-ASW 1.7 Software
(Olympus). The number of CB+ neurons and the number of
interneurons that co-express CB and SST were then quantified
using the NIH ImageJ Software.
Terminal Deoxynucleotidyl
Transferase-Mediated UTP Nick End
Labeling (TUNEL) Assay
To measure apoptotic cell death, TUNEL assay was conducted
according to the protocol of the manufacturer of the in situ cell
death detection kit (Roche). Briefly, after incubation with the
blocking solution (3% H2O2 in methanol) for 10 min at room
temperature, free-floating brain sections were rinsed, incubated
with the permeabilization solution (0.1% Triton X-100 in 0.1%
sodium citrate) for 2 min at 4◦C and labeled with the TUNEL
reaction mixture for 60 min at 37◦C. After rinsing, sections
were then transferred onto slides, dried and coverslipped.
TUNEL staining images were obtained using an Olympus IX71
microscope and TUNEL+ neurons were counted using the NIH
ImageJ Software.
Western Blot
Using Western blot, we examined the protein levels of
GAD65/67, two apoptosis-related molecules (Bcl-2 and Bax) and
three CBPs (PV, CB and CR). Twenty-four hours after last drug
treatment, rats were deeply anesthetized with pentobarbital and
their brains rapidly removed and dissected to obtain mPFC
as previously described (Gearhart et al., 2006). Tissue from
individual rats was immediately homogenized on ice in ice-cold
lysis buffer [137 mM NaCl, 20 mM Tris–HCl (pH 8.0), 1% NP-
40, 10% glycerol, 1 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml
leupeptin, 0.5 mM sodium vanadate], sonicated, and centrifuged.
The supernatants were stored at−80◦C until required.
Samples containing 20 µg of protein were resolved by
10% (for GAD65/67, CB and CR), 12.5% (for Bcl-2 and Bax)
acrylamide gels using Laemmli–SDS-PAGE, or 15% (for PV)
acrylamide gels using Tricine-SDS-PAGE (Schagger, 2006), and
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transferred electrophoretically to a polyvinylidene difluoride
(PVDF) membrane (Millipore, Bedford, MA, USA). The PVDF
membranes with the pore size being 0.2 µm for PV and 0.45 µm
for other proteins containing the proteins of interest were then
blocked with 5% non-fat milk diluted in Tris-buffered saline-
Tween (TBST) [150 mM NaCl, 10 mM Tris-HCl (pH 7.5)
and 0.1% Tween] for 1 h at room temperature and incubated
overnight at 4◦C in primary antibodies diluted in TBST
containing 5% non-fat milk (GAD65/67: rabbit anti-GAD65/67,
1:5000, ab11070, Abcam; Bcl-2: rabbit anti-Bcl-2, 1:1000, ab7973,
Abcam; Bax: rabbit anti-Bax, 1:1000, ab32503, Abcam; PV: rabbit
anti-Parvalbumin, 1:2000, 195002, Synaptic Systems, Germany;
CB: rabbit anti-calbindin, 1:20,000, CB-38a, Swant; CR: rabbit
anti-calretinin, 1:10,000, 7699/3H, Swant; β-actin: mouse anti-
β-actin, 1:20,000, 3700, Cell Signaling, Danvers, MA, USA).
The next day, membranes were rinsed three times with TBST
(8 min each time) and incubated for 2 h with horseradish
peroxidase-conjugated goat anti-rabbit or anti-mouse secondary
antibodies (1:2500–20,000, Santa Cruz Biotechnology) diluted
in TBST containing 5% non-fat milk. Following another three
TBST rinses, proteins of interest were visualized using an ECL
system (Pierce, Rockford, IL, USA) and Kodak XBT-1 film. The
immunoreactive signals of the target proteins were quantified
by densitometry and the values were corrected based on their
corresponding β-actin levels. All results were normalized by
taking the value of the vehicle group as 100%.
Statistical Analyses
All the results were expressed as the mean ± SEM. The
learning performance during the training period was
analyzed using repeated measures analysis of variance
(ANOVA) with training day as a within-subject factor
and group as a between-subject factor. The percentage
time animals swam in the target, adjacent and opposite
quadrants in the probe tests was compared with each other
using Wilcoxon signed rank test. The number of PV+,
CB+, CR+, GAD65/67+ and TUNEL+ neurons in three
mPFC subregions was analyzed using two-way ANOVA
with group and subregion (Cg, PrL and IL) as the factors
and the post hoc analyses of main effects of group were
conducted using the Fisher’s least significant difference (LSD)
test. One-way ANOVA, followed by the Fisher’s LSD test
was used to examine treatment effects in various measures,
including the escape latency within each training day, the
time spent in the target quadrant during probe tests, the
cell counts within each mPFC subregion and the western
blot results. The significance level for all statistical tests was
P < 0.05.
RESULTS
Subchronic MK-801 Treatment During
Adolescence Delayed Reversal Learning in
the Water Maze
We found that subchronicMK-801 treatment during adolescence
did not affect reference memory in the Morris water maze
(Figure 3A). Specifically, the escape latency to the platform
decreased over the 5 days of training (main time effect:
F(4,136) = 67.21, P < 0.001), indicating that animals spent
less time reaching the platform as the training proceeded.
There was a lack of main group effect (F(3,34) = 1.12,
P = 0.36) and group × day interaction (F(12,136) = 0.65,
P = 0.79), suggesting that spatial learning performance was
comparable among all treatment groups. This result was
confirmed by the probe test (Figure 3B, left side panel), in
which all the groups exhibited the highest spatial preference
for the target quadrant. Direct comparison of the percentage
time animals swam in the target, adjacent and opposite
quadrants using Wilcoxon signed rank test showed that
all animals spent significantly more time swimming in the
target than other quadrants (Ps < 0.05) and no significant
treatment effect was found for the time spent in the target
quadrant.
Regarding the performance in the reversal learning task
(Figure 3A), repeated measures ANOVA on the escape
latency to the platform over the 4 days of training showed
significant main effects of day (F(3,102) = 20.83, P < 0.001)
and group (F(3,34) = 3.25, P = 0.034), but no interaction of
the two factors (F(9,102) = 0.59, P = 0.80). Looking at group
differences in the training session day by day, we found
that compared with the control group, only animals in the
group of MK-801 0.2 mg/kg spent more time in relocating
the platform location at the acquisition Day 1 (P = 0.009)
and Day 2 (P = 0.024). Similar trends for this group were
observed in the following training days, although statistical
significance was not reached. These results suggest that animals
receiving 0.2 mg/kg of MK-801 had delayed reversal learning
compared to the control animals. After training, the probe test
(Figure 3B, right side panel) revealed that the four groups
successfully differentiated the target from other quadrants
(Ps < 0.05), indicating that all the animals eventually acquired
the new platform position. Additionally, we noticed a subtle but
statistically significant difference between MK-801 0.2 mg/kg
group and the control group concerning the time in the
target quadrant (P = 0.027), which suggests that 0.2 mg/kg of
MK-801 treatment may mildly compromise memory retrieval
performance.
Finally, we analyzed swimming speed during the acquisition
phases of reference memory and reversal learning to determine
whether MK-801 induces general sensorimotor deficits (Vorhees
and Williams, 2006). As shown in Figure 3C, there was no
significant difference in swimming speed among treatment
groups, thus ruling out the possibility that differential
performance in reversal learning may be ascribed to differences
in general sensorimotor skills.
Subchronic MK-801 Treatment During
Adolescence Decreased PV+ and CB+ Cell
Densities in the mPFC
Twenty Four hour after drug cessation (Figure 4A), in
the cell counts of PV+ interneurons, two-way ANOVA
revealed significant main effects of group (F(3,36) = 4.03,
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FIGURE 3 | Effects of subchronic treatment of MK-801 (0.1, 0.2, 0.4 mg/kg, once daily) during adolescence (PND 29–42) on reference memory and
reversal learning in the Morris water maze. (A) Mean escape latency in the reference memory and reversal learning tasks over training days. (B) The percentage
time animals swam in the target, adjacent and opposite quadrants during the probe tests. (C) Mean swim speed in the reference memory and reversal learning tasks
over training days. n = 9–10 per group. ∗p < 0.05, ∗∗p < 0.01 compared with the target quadrant. #p < 0.05 compared with the vehicle group.
P = 0.014) and subregion (F(2,36) = 43.12, P < 0.001), but no
significant interaction effect of group × subregion was observed
(F(6,36) = 1.20, P = 0.33). Post hoc analyses of the main effect of
group showed that MK-801 treatment at all the doses induced
a significant reduction in the cell counts of PV+ interneurons
(0.1 mg/kg, P = 0.014; 0.2 mg/kg, P = 0.018; 0.4 mg/kg, P = 0.003).
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The reduction was primarily found in the Cg (0.1 mg/kg, −26%,
P = 0.04; 0.2mg/kg,−28%, P = 0.03; 0.4mg/kg,−35%, P = 0.009),
but not in other subregions.
As for CB+ cells, it is notable that a subpopulation of
pyramidal neurons in both superficial and deep layers was weakly
stained for CB, as reported in previous studies (Gabbott et al.,
1997; Gonchar and Burkhalter, 1997; Caballero et al., 2014).
Failing to differentiate bonafide interneurons from pyramidal
neurons, we therefore counted the number of CB+ neurons
instead of CB+ interneurons. Two-way ANOVA only revealed
a significant main effect of subregion (F(2,36) = 29.66, P < 0.001),
without a main effect of group (F(3,36) = 1.84, P = 0.16) and the
group× subregion interaction (F(6,36) = 0.50, P = 0.80). However,
directly examining the treatment effect within each subregion
showed that the cell counts of CB+ neurons in the Cg were
also significantly decreased by MK-801 treatment (0.1 mg/kg,
−20%, P = 0.007; 0.2 mg/kg,−24%, P = 0.003; 0.4 mg/kg,−27%,
P = 0.001), whereas CB+ neurons in other subregions were
unaffected.
To further explore the possibility that the CB+ neuronal
density reduction could occur within specific interneuron
populations, we labeled a group of interneurons that co-express
CB and SST, another selective interneuron marker, within the
Cg subregion using double-fluorescence immunohistochemistry
(Figure 5). Considering the layer-specific distribution of CB+
neurons, i.e., the majority of weakly CB+ neurons were found
in superficial layers (Figure 4, middle panel), we analyzed
the superficial and deep layers separately. In both types of
layers, the cell counts of CB+ neurons were significantly
reduced inMK-801-treated animals compared to control animals
(Superficial layers: 0.1mg/kg,−33%, P = 0.002; 0.2mg/kg,−51%,
P < 0.001; 0.4 mg/kg, −47%, P < 0.001. Deep layers: 0.1 mg/kg,
−27%, P = 0.004; 0.2 mg/kg, −32%, P = 0.001; 0.4 mg/kg,
−33%, P = 0.001), which is consistent with our previous
immunohistochemical findings. As for the SST+ interneurons,
while MK-801 treatment did not affect the cell density in the
superficial layers, in the deep layers the treatment induced
significant reduction in the 0.2 mg/kg group (−38%, P = 0.012).
For interneurons that express CB in combination with SST, in
the vehicle-treated animals, these interneurons accounted for
∼11% (21/191) of CB+ neurons and ∼60% (21/35) of SST+
neurons in the superficial layers and the ratios changed to
58% (35/61) and 70% (35/51), respectively, in the deep layers.
Importantly, the cell counts of these CB+ interneurons were
also significantly decreased by MK-801 treatment (Superficial
layers: 0.1 mg/kg, −39%, P = 0.003; 0.2 mg/kg, −48%, P = 0.001;
0.4 mg/kg, −57%, P < 0.001. Deep layers: 0.1 mg/kg, −41%,
P = 0.002; 0.2 mg/kg, −50%, P < 0.001; 0.4 mg/kg, −50%,
P < 0.001).
Seven days after drug cessation (Figure 4B), in the cell
counts of PV+ interneurons, again significant main effects of
group (F(3,36) = 4.38, P = 0.010) and subregion (F(2,36) = 41.19,
P < 0.001) were observed without a significant group ×
subregion interaction (F(6,36) = 0.56, P = 0.76). Post hoc
analyses revealed that both MK-801 0.2 mg/kg (P = 0.002)
and 0.4 mg/kg groups (P = 0.010) had significantly lower
density of PV+ neurons in the mPFC, but only the 0.2 mg/kg
group exhibited such reduction in the Cg (P = 0.022).
Similar results were found with CB+ neurons, which showed
significant main effects of group (F(3,36) = 4.35, P = 0.010)
and subregion (F(3,36) = 27.75, P < 0.001), but not group
× subregion interaction (F(6,36) = 0.40, P = 0.87). Treatment
effects were only observed in the 0.2 mg/kg group, given that
the reduction of CB+ neurons in this group was significant
in the mPFC as a whole (P = 0.013) as well as in the Cg
(P = 0.032).
Notably, at both time points, no significant group effect was
observed for CR+ interneurons in the mPFC as a whole or in any
subregions (Figure 4, bottom panel).
Repeated NMDA Receptors Blockade
Decreased Protein Expression Levels of PV
and CB Without Inducing Neuronal Loss
To examine whether reduced PV+ and CB+ neuron densities
result from neuronal death or a downregulation of these CBPs,
we conducted the following analyses 24 h after drug cessation.
First, the number of GAD65/67+ interneurons was quantified to
evaluate the total number of interneurons. If a real numerical loss
of interneurons occurred followingMK-801 treatment, we would
expect a reduction in the GAD65/67+ interneuron density.
Nonetheless, no significant change was observed in MK-801-
treated animals (Figure 6A), suggesting that reduced densities
of PV+ and CB+ interneurons are unlikely a result of neuronal
death. Similarly, the protein levels of GAD65/67 were unaltered
by MK-801 treatment (Figure 6B). Moreover, to investigate
the potential apoptotic effects of subchronic MK-801 treatment
during adolescence, we compared the number of apoptotic cells
stained with TUNEL among four treatment groups and did
not observe any significant group differences (Figure 6C). The
expression levels of two apoptosis-related molecules, Bax and
Bcl-2, and their ratio were comparable among four groups
as well (Figure 6D), lending further support to the notion
that subchronic MK-801 treatment during adolescence had
minimal influence on apoptosis. Finally, significant reductions
in the expression levels of PV (0.1 mg/kg, −22%, P = 0.033;
0.2 mg/kg, −26%, P = 0.013; 0.4 mg/kg, −33%, P = 0.003)
and CB (0.1 mg/kg, −17%, P = 0.030; 0.2 mg/kg, −24%,
P = 0.005; 0.4 mg/kg, −27%, P = 0.002), but not CR, in
MK-801-treated animals were observed (Figure 6E), indicating
that reduced densities of PV+ and CB+ neurons may be
attributed to downregulation of PV and CB expression
levels.
DISCUSSION
In this study, we examined how repeated blockade of NMDA
receptors by MK-801 during adolescence would affect PFC-
mediated cognitive functions and GABAergic interneurons in
rat mPFC. We found that rats receiving MK-801 treatment
exhibited delayed reversal learning in the water maze without
affecting acquisition. In addition, the treatment reduced the
density of PV+ and CB+ cells in rat mPFC, which persisted
for (at least) 7 days after drug cessation in the 0.2 mg/kg
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FIGURE 4 | Effects of subchronic treatment of MK-801 (0.1, 0.2, 0.4 mg/kg, once daily) during adolescence (PND 29–42) on relative density of PV+,
CB+ and CR+ neurons in rat mPFC 24 h (A) and 7 days (B) after drug cessation. Representative sections show immunoreactivity of each type of neurons in
the cingulate subregion in animals receiving either vehicle or MK-801 (0.2 mg/kg) treatment. n = 4 per group. ∗p < 0.05, ∗∗p < 0.01 compared with the vehicle
group. Cg, cingulate cortex; PrL, prelimbic cortex; IL, infralimbic cortex.
group. We also demonstrated that the reduction in PV+ and
CB+ neuron densities resulted from decreased PV and CB
expression levels, rather than neuronal death, because at 24 h
after drug cessation, the density of apoptotic cells and the
expression levels of apoptosis-related molecules (Bcl-2 and Bax)
were unaffected by MK-801 treatment, whereas the reduced
expression levels of PV and CB in MK-801-treated animals were
observed.
Previous studies in adult animals have demonstrated that
subchronic treatment of NMDA receptor antagonists including
PCP and MK-801 did not affect initial acquisition, but selectively
impaired reversal learning (Abdul-Monim et al., 2007; Beninger
et al., 2009). Here, for the first time we show that adolescent
MK-801 treatment delayed reversal learning in the water maze.
The normal performance in the reversal learning task requires
cognitive flexibility, which is thought to be mediated by the
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FIGURE 5 | Effects of subchronic treatment of MK-801 (0.1, 0.2, 0.4 mg/kg, once daily) during adolescence (PND 29–42) on relative density of CB+
interneurons that co-express somatostatin (SST) in the superficial and deep layers of the cingulate subregion 24 h after drug cessation.
Representative confocal images show both superficial and deep layers of the cingulate subregion immunostained for DAPI, CB and SST in animals receiving either
vehicle or MK-801 (0.2 mg/kg) treatment. Interneurons in superficial (white box) and deep (yellow box) layers are shown in the bottom row. CB+/SST+ interneurons
are labeled with arrowhead. n = 4 per group. ∗p < 0.05, ∗∗p < 0.01 compared with the vehicle group.
PFC (Kesner and Churchwell, 2011). Together with our previous
finding of the deficits in spatial working memory, another
mPFC-dependent cognitive function, by the same treatment
regimen (Li et al., 2011), these results suggest that subchronic
NMDA receptor blockade during adolescence disrupts mPFC
functions.
Cortical interneuron impairments have been hypothesized
to contribute to cognitive disturbances in schizophrenia (Lewis
et al., 2005). In this study, we found that subchronic
MK-801 treatment during adolescence significantly decreased
the numbers of PV+ and CB+ cells in rat mPFC, but did not
affect CR+ interneurons. This is in line with post-mortem studies
of schizophrenia (Daviss and Lewis, 1995; Reynolds et al., 2001;
Beasley et al., 2002; Cotter et al., 2002) and animal studies
applying chronic NMDA receptor antagonism in neonatal or
adult rodents (Cochran et al., 2003; Abekawa et al., 2007;
Wang et al., 2008; Turner et al., 2010; Amitai et al., 2012).
Our finding is also consistent with a recent study showing that
5 days of PCP treatment in early adolescence resulted in the
reduction of the PV mRNA (Thomsen et al., 2010). However,
another study in juvenile rats reported that PV+ cell counts
were unaltered by the low-dose MK-801 treatment from PND
35–56 (Braun et al., 2007). The discrepancy could be explained
by dose differences, given that the dose in Braun et al.’s (2007)
study (0.02 mg/kg) is much lower than our study (0.1, 0.2
and 0.4 mg/kg). Another possible explanation is that Braun
et al.’s (2007) study did not cover the cingulate cortex, the
subregion where the most prominent effects were found in our
study.
In contrast to the popular research interest in the PV+
interneurons, the effects of NMDA receptor blockade on
CB+ interneurons have been rarely investigated. This class of
interneurons deserves more attention actually, given that deficits
have been reported in schizophrenic patients (Beasley et al.,
2002; Cotter et al., 2002) and related animals models, such as
isolation rearing from early adolescence (Harte et al., 2007)
and neonatal separation (Helmeke et al., 2008). Here, we found
that adolescent MK-801 treatment reduced the numbers of CB+
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FIGURE 6 | Investigation of the mechanisms of MK-801-induced reductions in GABAergic interneurons. Effects of subchronic treatment of MK-801
(0.1, 0.2, 0.4 mg/kg, once daily) during adolescence (PND 29–42) on the density of GAD65/67+ neurons (A) and the protein levels of GAD65/67 (B) the density of
apoptotic cells (C) the expression levels of two apoptosis-related molecules (Bax and Bcl-2) and their ratio (D) and expression levels of three CBPs.
(E) Representative sections show GAD65/67-immunoreactive neurons (A) and apoptotic cells (C, arrowhead-labeled), respectively, in the cingulate subregion in
animals receiving either vehicle or MK-801 (0.2 mg/kg) treatment. n = 4 per group for cell counts and n = 5 per group for other results. ∗p < 0.05, ∗∗p < 0.01
compared with the vehicle group. Cg, cingulate cortex; PrL, prelimbic cortex; IL, infralimbic cortex.
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neurons. Given that CB is expressed in a variety of interneurons
as well as pyramidal cells, we further demonstrated that the
reduction was significant in a population of CB+ interneurons
that co-express SST, another selective GABAergic neuron
marker, suggesting that the cell densities of this specific CB+
interneuron population were indeed decreased by adolescent
MK-801 treatment.
The reduction in PV+ and CB+ cell counts may represent
a loss of these neurons or a downregulation of PV and CB
proteins. Our results about the density of apoptotic cells
and expression levels of apoptosis-related molecules and
these CBPs support that the latter mechanism is more likely
in our study. This is consistent with previous observations
that the apoptotic effect of MK-801 is rather limited in
adolescent rat brains (Ikonomidou et al., 1999). How
repeated blockade of NMDA receptors during adolescence
leads to PV and CB downregulation is still unclear. It has
been reported that systematic injection of MK-801 for
five consecutive days from PND35 to PND40 resulted in
prefrontal disinhibition in rats (Thomases et al., 2013).
One possibility is that downregulating PV expressions may
simply serve as a compensatory response to the cortical
hyperactive state, as PV deficiency could facilitate GABA
release (Vreugdenhil et al., 2003), thus increasing the
inhibitory signal to pyramidal neurons. Alternatively but
not exclusively, the PV and CB downregulation could be
ascribed to the disrupted maturation of the GABAergic
signaling during adolescence. The normal periadolescent
development of rat mPFC involves the upregulation of these
CBP expression levels (Caballero et al., 2014). This process
is activity-dependent (Philpot et al., 1997; Patz et al., 2004)
and accompanies other developmental changes of cortical
GABAergic neurotransmission at various levels, including
expression changes of glutamate receptors, maturation of
perisomatic innervation and electrophysiological properties, etc.
(Le Magueresse and Monyer, 2013). Considering the essential
role of NMDA receptors in regulating the periadolescent
maturation of the GABAergic networks (Thomases et al., 2013),
it is possible that MK-801 treatment may impede the normal
upregulation of these CBPs, although the exact mechanisms
awaits future studies.
We did not find significant changes of CR+ neuron density
following adolescent MK-801 treatment. The dissociation
between CR+ and other types of interneurons has been
well documented in several post mortem studies (Reynolds
et al., 2001; Zhang and Reynolds, 2002) and animal studies
(Braun et al., 2007; Harte et al., 2007) and might be associated
with differential distribution of glutamate receptors in these
neurons (Catania et al., 1998). In addition, considering
that PV+ and CB+ interneurons preferentially innervate
pyramidal cells to exert inhibitory control (DeFelipe et al.,
1989a,b), whereas CR+ neurons mainly form synaptic
contacts with other types of inhibitory neurons and play a
disinhibitory role (Gulyás et al., 1996; DeFelipe et al., 1999),
it seems that interneurons having direct connections with
pyramidal cells are more profoundly affected following MK-801
treatment.
The cingulate cortex plays an important role in cognitive
control in both rodents (Ragozzino and Rozman, 2007; Kesner
and Churchwell, 2011) and primates (Medalla and Barbas, 2009).
In this study, we found that the mPFC interneuron deficits
caused byMK-801 treatment were specific in the cingulate cortex
when detected 24 h and 7 days after drug cessation. The disrupted
excitatory and inhibitory balance resulting from interneuron
reductions in this region may thus contribute to cognitive
deficits induced by MK-801 treatment. Besides, our treatment
regime did not cause obvious alterations in the prelimbic cortex,
which plays a direct role in cognitive functions homologous to
the dorsolateral PFC of primates (Hoover and Vertes, 2007).
This does not necessarily indicate that the prelimbic cortex
was spared by adolescent NMDA antagonism. Indeed, Cochran
et al. (2003) found that chronic PCP treatment did not affect
the number of PV-labeled cells in this region, but significantly
decreased PV mRNA expression. Therefore, future studies
adopting different measurements of interneuron functions are
warranted to examine the potential effects of MK-801 treatment
in this region.
Notably, the interneuron deficits we observed persisted
7 days after drug cessation. Consistent with a recent study
showing that periadolescent exposure to MK-801 (PND 35–40)
induced prefrontal disinhibition that endures through adulthood
(Thomases et al., 2013), this finding indicates that NMDA
receptor signaling is critically involved in the functional
maturation of GABAergic circuits in the mPFC. This effect was
only found in the MK-801 group of 0.2 mg/kg, which has been
shown to cause long-term impairment of cognitive functions (Li
et al., 2011), further highlighting 0.2 mg/kg as the appropriate
dose for building animal models of schizophrenia.
In summary, our findings reveal that repeated NMDA
receptors blockade during adolescence reduced the density of
PV+ and CB+ interneurons in mPFC, which probably resulted
from a downregulation of PV and CB expression levels, but not
to neuronal death. These GABAergic deficits may be associated
with impairments in mPFC-mediated cognitive functions. Taken
together, our data suggest that adolescent NMDA antagonism is
a useful tool for mimicking the behavioral and neuropathological
changes of schizophrenia. Future studies should be conducted to
elucidate the GABAergic deficits in other aspects and to evaluate
putative pharmacological interventions.
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